IBM Ventures participated in a $20m round for the neurological disease diagnostics technology developer, a spinout from Tel Aviv University.

The ophthalmic treatment developer has now raised almost $36m in total, with CR-CP Life Science Fund having led a $25m round.

Osaka spinout Cuorips has added $14.7m to its coffers from investors including vehicles for the institution and Kyoto University, just three months after collecting $19.3m.

The database software provider more than doubled its valuation to nearly $5.8bn in a series E round that boosted its cash on hand to about $500m.

Softbank Investment Advisors and existing investor GV contributed to a series C round boosting the drug discovery platform developer's overall funding to over $640m.

The Keio University-backed digital medicine developer has secured $19.3m from a consortium including several Japanese corporations.

Dai-ichi Life, Itochu Technology Ventures, Koshidaka and Toyoshima CVC were among the investors that backed the medical therapy booking platform’s $19.3m round.

Legend Capital was among the investors in a round of undisclosed size for Kunlun, an AI chip subsidiary of Baidu, at a valuation of about $2bn.

Baxter Healthcare was among the investors in the $65m first close of a private placement the biosimilar drug developer has pushed to $100m.

Alphabet subsidiary GV was part of a consortium in a round that will fund the progress of the precision medicine developer's lead drug candidate into the clinic.